NCT00333723View on ClinicalTrials.gov

AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone

PHASE4CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

July 28, 2000

Primary Completion Date

January 6, 2003

Study Completion Date

January 6, 2003

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00333723 - AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone | Biotech Hunter | Biotech Hunter